Pepperstone logo
Pepperstone logo
  • English
  • Italiano
  • Español
  • Français
  • Ways to trade

    Pricing

    Trading accounts

    Pro

    Premium clients

    Refer a friend

    Active trader program

    Trading hours

    24-hour trading

    Maintenance schedule

  • Trading platforms

    Trading platforms

    TradingView

    Pepperstone platform

    MetaTrader 5

    MetaTrader4

    cTrader

    Integrations

    Trading tools

  • Markets

    Markets to trade

    Forex

    Shares

    ETFs

    Indices

    Commodities

    Currency Indices

    Cryptocurrencies

    Dividends for index CFDs

    Dividends for share CFDs

    CFD forwards

  • Market analysis

    Market news

    Navigating markets

    The Daily Fix

    Meet the analysts

  • Learn to trade

    Trading guides

    CFD trading

    Forex trading

    Commodity trading

    Stock trading

    Cryptocurrency trading

    Bitcoin trading

    Technical analysis

    Day trading

    Scalping trading

    Upcoming IPOs

    Gold trading

    Oil trading

    Webinars

  • Partners

  • About us

  • Help and support

  • Professional

  • English
  • Italiano
  • Español
  • Français

Analysis

US500

The Daily Fix: Moderna drug trials not all the bulls had hoped for

Chris Weston
Chris Weston
Head of Research
May 19, 2020
Share
Risk-on, risk-off the saying goes, but these are choppy markets and just when you think the bulls have an upper hand, risk takes a bit of a dive.

Today we’re told (in the latter stage of US trade) that a STAT “expert report” has downplayed the Moderna vaccine trial, which most had listed as one of the inspirations behind yesterday’s market rally. The report suggests “there’s no way to know how impressive, or not, the vaccine may be” and that “we don’t know if the antibodies are durable”.

I personally felt the large driver of Monday’s move was down to Fed chair Powell’s comments, a solid rally in European equities and moves in commodities and crude more broadly – today, we are seeing how much of the vaccine was priced and shows just how important the markets see the vaccine to mitigate what is essentially the biggest market risk – the prospect of a fresh wave of COVID-19 cases, that leads to renewed shutdown fears.

(Top pane – S&P500 futures/red circle indicates the Asia close)

20_05_2020_DFX1.png

(Source: Bloomberg)

The move lower in the S&P500 has left equities lower on the day, with the S&P500 -1.1%, NAS100 -0.4% and the Russell 2000 -2%. All sectors closed lower, although energy (-2.9%) and financials (-2.5%) led the declines with 79.8% of stocks closing in the red. The Asian open is looking a tad dicey, with Aussie SPI futures -1.5% and weaker tape in Hang Seng and Nikkei futures. The breakout in the ASX 200 is on thin ice, and the bulls will need to support the open, or we run the risk of moving back to 5350.

Failed breaks in the JPY crosses

The move lower in equities was good for 50-pips in the AUDUSD, where the pair had moved to 0.6585, breaking to the highest levels since 9 March, before taking the hit. We’re left with an ominous-looking candle on the daily chart, and one where a lower low today could see attract greater profit-taking. It probably won’t shock to see the similar price action on the US500 or NAS100, given they’re effectively the same vehicle these days. The 20-day rolling correlation between S&P 500 futures and AUDUSD sits at 0.77, with AUDJPY at 0.80.

AUDJPY pushed to 70.96 but has found sellers above the 100-day MA (70.58) but seems to be holding its breakout high of 70.17. One to watch through trade, as this could be somewhat of a lead indicator through Asia today. EURJPY is another JPY cross getting some attention has been well traded, with sellers on the 117.78 break – This could be telling if price rolls over through Asia today.

20_05_2020_DFX2.png

USDJPY, another of the JPY crosses, where price made a higher high, but failed to hold the bid and failed breaks could manifest in Asia.

20_05_2020_DFX3.png

The session percentage change masks the late session charge for the JPY, with the currency net lower vs all major currencies ex-BRL, with NOKJPY and NZDJPY the stars of the show. That said, again, as the S&P500 moved lower into the close the JPY and the USD caught a bid, with the VIX index – a barometer of risk and implied movement – pushing back above 30%, with good buying of S&P500 1-month 25delta put vol (+2.3 vols at 31.97%).

Bond and gold moves

After yesterday’s strong move in breakevens (inflation-expectations), we see 5-year expectations -3bp to 82bp and 10s -2bp to 1.14%. We’ve seen a better bid in gold (XAUUSD), with the metal (+0.8%) finding buyers all through EU and into US trade, with price holding the 5-day EMA and holding a new closing high. Gold miners have rallied strongly, with the GDX ETF (gold miners ETF) closing +3.6%, and this offers a belief from equity investors that the yellow metal is headed higher.

On the docket ahead there is little data to worry Asia, while UK CPI (16:00 AEST/07:00 BST – headline expected to decline 0.1% MoM) may get some focus given the delicate set-up in

GBPUSD daily chart – make or break time.

20_05_2020_DFX4.png


Related articles

The Daily Fix: A truly cyclical rally in risk - reflation is on

The Daily Fix: A truly cyclical rally in risk - reflation is on

EUR
US
The Daily Fix: Big flows in GBP, EUR and gold

The Daily Fix: Big flows in GBP, EUR and gold

EUR
GBP
Gold

Most read

1

The disinflationary message seen in commodities and rates markets

2

Will the BOJ be the last dovish domino to fall?

3

Trader thoughts - the conflicting forces dictating EURUSD flow

Ready to trade?

It's quick and easy to get started. Apply in minutes with our simple application process.

Get startedSubscribe to The Daily Fix

The material provided here has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Whilst it is not subject to any prohibition on dealing ahead of the dissemination of investment research we will not seek to take any advantage before providing it to our clients.

Pepperstone doesn’t represent that the material provided here is accurate, current or complete, and therefore shouldn’t be relied upon as such. The information, whether from a third party or not, isn’t to be considered as a recommendation; or an offer to buy or sell; or the solicitation of an offer to buy or sell any security, financial product or instrument; or to participate in any particular trading strategy. It does not take into account readers’ financial situation or investment objectives. We advise any readers of this content to seek their own advice. Without the approval of Pepperstone, reproduction or redistribution of this information isn’t permitted.

Other Sites

  • The Trade Off
  • Partners
  • Group
  • Careers

Ways to Trade

  • Pricing
  • Trading Accounts
  • Pro
  • Active trader Program
  • Trading Hours

Platforms

  • Trading Platforms
  • Trading tools

Markets and Symbols

  • Forex
  • Shares
  • ETFs
  • Indicies
  • Commodities
  • Currency indicies
  • Cryptocurrencies
  • CFD Forwards

Analysis

  • Navigating Markets
  • The Daily Fix
  • Pepperstone Pulse
  • Meet the Analysts

Learn to Trade

  • Trading Guides
  • Videos
  • Webinars
Pepperstone logo
support@pepperstone.com
0035725030573
195, Makarios III Avenue, Neocleous House,
3030, Limassol Cyprus
  • Legal documents
  • Privacy policy
  • Website terms and conditions
  • Cookie policy

© 2025 Pepperstone EU Limited
Company Number ΗΕ 398429 | Cyprus Securities and Exchange Commission Licence Number 388/20

Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trading derivatives is risky. It isn't suitable for everyone and, in the case of Professional clients, you could lose substantially more than your initial investment. You don't own or have rights in the underlying assets. Past performance is no indication of future performance and tax laws are subject to change. The information on this website is general in nature and doesn't take into account your or your client's personal objectives, financial circumstances, or needs. Please read our legal documents and ensure you fully understand the risks before you make any trading decisions. We encourage you to seek independent advice.

Pepperstone EU Limited is a limited company registered in Cyprus under Company Number ΗΕ 398429 and is authorised and regulated by the Cyprus Securities and Exchange Commission (Licence Number 388/20). Registered office: 195, Makarios III Avenue, Neocleous House, 3030, Limassol Cyprus.

The information on this site is not intended for residents of Belgium, Spain or the United States, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.